Outcomes Linked to Eligibility for Stem Cell Transplantation Trials in Diffuse Cutaneous Systemic Sclerosis (2021)
Attributed to:
Functional and molecular diversity of skin fibroblasts in systemic sclerosis.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
Volume: Arthritis Rheumatol. 2021; 73 (suppl 10).